CoChat

Clinical Utility of KRAS and BRAF Mutations in a Cohort of Patients With Colorectal Neoplasms Submitted for Microsatellite Instability Testing

Cushman-Vokoun, Allison M., Stover, Daniel G., Zhao, Zhiguo, Koehler, Elizabeth A., Berlin, Jordan D., Vnencak-Jones, Cindy L. · 2013 · Clinical Colorectal Cancer
Cited by 24

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.clcc.2013.04.005

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 41

  1. Fearon, 1990, A genetic model for colorectal tumorigenesis, Cell, 61, 759, 10.1016/0092-8674(90)90186-I · DOI · Paper page
  2. de la Chapelle, 2010, Clinical relevance of microsatellite instability in colorectal cancer, J Clin Oncol, 28, 3380, 10.1200/JCO.2009.27.0652 · DOI · Paper page
  3. Walther, 2008, Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis, Gut, 57, 941, 10.1136/gut.2007.135004 · DOI · Paper page
  4. Span, 1996, A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients, Int J Cancer, 69, 241, 10.1002/(SICI)1097-0215(19960621)69:3<241::AID-IJC15>3.0.CO;2-A · DOI · Paper page
  5. Bazan, 2002, Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype, Ann Oncol, 13, 1438, 10.1093/annonc/mdf226 · DOI · Paper page
  6. Karapetis, 2008, K-ras mutations and benefit from cetuximab in advanced colorectal cancer, N Engl J Med, 359, 1757, 10.1056/NEJMoa0804385 · DOI · Paper page
  7. Davies, 2002, Mutations of the BRAF gene in human cancer, Nature, 417, 949, 10.1038/nature00766 · DOI · Paper page
  8. Wang, 2003, BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair, Cancer Res, 63, 5209
  9. Deng, 2004, BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer, Clin Cancer Res, 10, 191, 10.1158/1078-0432.CCR-1118-3 · DOI · Paper page
  10. Khambata-Ford, 2007, Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab, J Clin Oncol, 25, 3230, 10.1200/JCO.2006.10.5437 · DOI · Paper page
  11. Lang, 2011, Optimized allele-specific real-time PCR assays for the detection of common mutations in KRAS and BRAF, J Mol Diagn, 13, 23, 10.1016/j.jmoldx.2010.11.007 · DOI
  12. Sundstrom, 2010, KRAS analysis in colorectal carcinoma: analytical aspects of pyrosequencing and allele-specific PCR in clinical practice, BMC Cancer, 10, 660, 10.1186/1471-2407-10-660 · DOI · Paper page
  13. Sinicrope, 2009, Clinical implications of microsatellite instability in sporadic colon cancers, Curr Opin Oncol, 21, 369, 10.1097/CCO.0b013e32832c94bd · DOI · Paper page
  14. Edelmann, 1997, Mutation in the mismatch repair gene Msh6 causes cancer susceptibility, Cell, 91, 467, 10.1016/S0092-8674(00)80433-X · DOI · Paper page
  15. Lecomte, 2002, Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis, Int J Cancer, 100, 542, 10.1002/ijc.10526 · DOI · Paper page
  16. Takeda, 1993, Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA), Hum Mutat, 2, 112, 10.1002/humu.1380020209 · DOI
  17. Finkelstein, 1993, Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis, Arch Surg, 128, 526, 10.1001/archsurg.1993.01420170056008 · DOI · Paper page
  18. Finkelstein, 1993, Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type, Cancer, 71, 3827, 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO;2-N · DOI · Paper page
  19. Zhao, 2008, Exclusive KRAS mutation in microsatellite-unstable human colorectal carcinomas with sequence alterations in the DNA mismatch repair gene, MLH1, Gene, 423, 188, 10.1016/j.gene.2008.07.014 · DOI
  20. Oliveira, 2004, Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status, Hum Mol Genet, 13, 2303, 10.1093/hmg/ddh238 · DOI · Paper page
  21. Zlobec, 2010, Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer, Int J Cancer, 127, 2569, 10.1002/ijc.25265 · DOI · Paper page
  22. Benhattar, 1993, Prognostic significance of K-ras mutations in colorectal carcinoma, Gastroenterology, 104, 1044, 10.1016/0016-5085(93)90272-E · DOI · Paper page
  23. Samowitz, 2005, Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers, Cancer Res, 65, 6063, 10.1158/0008-5472.CAN-05-0404 · DOI · Paper page
  24. Roth, 2010, Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial, J Clin Oncol, 28, 466, 10.1200/JCO.2009.23.3452 · DOI · Paper page
  25. Loupakis, 2009, KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer, Br J Cancer, 101, 715, 10.1038/sj.bjc.6605177 · DOI · Paper page
  26. Andreyev, 2001, Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study, Br J Cancer, 85, 692, 10.1054/bjoc.2001.1964 · DOI · Paper page
  27. Farina-Sarasqueta, 2010, The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients, Ann Oncol, 21, 2396, 10.1093/annonc/mdq258 · DOI · Paper page
  28. Gerlinger, 2012, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing, N Engl J Med, 366, 883, 10.1056/NEJMoa1113205 · DOI · Paper page
  29. Ogino, 2009, KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803, Clin Cancer Res, 15, 7322, 10.1158/1078-0432.CCR-09-1570 · DOI · Paper page
  30. Poehlmann, 2007, K-ras mutation detection in colorectal cancer using the pyrosequencing technique, Pathol Res Pract, 203, 489, 10.1016/j.prp.2007.06.001 · DOI
  31. Miyaki, 2004, Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer, Cancer Lett, 211, 105, 10.1016/j.canlet.2004.01.027 · DOI
  32. Su, 1986, Escherichia coli mutS-encoded protein binds to mismatched DNA base pairs, Proc Natl Acad Sci U S A, 83, 5057, 10.1073/pnas.83.14.5057 · DOI · Paper page
  33. Bouzourene, 2000, p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer, Eur J Cancer, 36, 1008, 10.1016/S0959-8049(00)00036-8 · DOI
  34. De Roock, 2010, Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab, JAMA, 304, 1812, 10.1001/jama.2010.1535 · DOI · Paper page
  35. Moerkerk, 1994, Type and number of Ki-ras point mutations relate to stage of human colorectal cancer, Cancer Res, 54, 3376
  36. He, 2009, PIK3CA mutations predict local recurrences in rectal cancer patients, Clin Cancer Res, 15, 6956, 10.1158/1078-0432.CCR-09-1165 · DOI · Paper page
  37. Samowitz, 2009, Microsatellite instability and survival in rectal cancer, Cancer Causes Control, 20, 1763
  38. Kalady, 2009, Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas, Dis Colon Rectum, 52, 1039, 10.1007/DCR.0b013e31819edbd4 · DOI
  39. Gaedcke, 2010, KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy, Radiother Oncol, 94, 76, 10.1016/j.radonc.2009.10.001 · DOI
  40. Chou, 2010, Microsatellite instability screening should be done for right-sided colon cancer patients less than 60 years of age, Int J Colorectal Dis, 25, 47, 10.1007/s00384-009-0815-y · DOI
  41. Hoogerbrugge, 2003, Very low incidence of microsatellite instability in rectal cancers from families at risk for HNPCC, Clin Genet, 63, 64, 10.1034/j.1399-0004.2003.630110.x · doi:10.1034/j.1399-0004.2003.630110.x

Cited by

See all 24

Metadata

Authors
Cushman-Vokoun, A. M., Stover, D. G., Zhao, Z., Koehler, E. A., Berlin, J. D., & Vnencak-Jones, C. L.
Venue
Clinical Colorectal Cancer
Publisher
Elsevier BV
Published
2013-09
Volume
12
Issue
3
Pages
168-178
ISSN
1533-0028
Cited by
24
References
10
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Utility of KRAS and BRAF Mutations in a Cohort of Patients With Colorectal Neoplasms Submitted for Microsatellite Instability Testing. https://app.cochat.ai/papers/10.1016/j.clcc.2013.04.005
The paper
Cushman-Vokoun, A. M., Stover, D. G., Zhao, Z., Koehler, E. A., Berlin, J. D., & Vnencak-Jones, C. L. (2013). Clinical Utility of KRAS and BRAF Mutations in a Cohort of Patients With Colorectal Neoplasms Submitted for Microsatellite Instability Testing. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2013.04.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.